Kliniske aspekter af Marfans syndrom

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Kliniske aspekter af Marfans syndrom. / Belsing, Tina Zimmermann; Lund, Allan Meldgaard; Søndergaard, Lars; Friis-Hansen, Lennart; Abildstrøm, Steen Zabell.

I: Ugeskrift for Laeger, Bind 173, Nr. 5, 2011, s. 337-42.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Belsing, TZ, Lund, AM, Søndergaard, L, Friis-Hansen, L & Abildstrøm, SZ 2011, 'Kliniske aspekter af Marfans syndrom', Ugeskrift for Laeger, bind 173, nr. 5, s. 337-42. <http://www.ugeskriftet.dk.ep.fjernadgang.kb.dk/portal/page/portal/LAEGERDK/UGESKRIFT_FOR_LAEGER/Artikelvisning?pUrl=/UGESKRIFT_FOR_LAEGER/TIDLIGERE_NUMRE/2011/UFL_2011_5/UFL_2011_173_5_337>

APA

Belsing, T. Z., Lund, A. M., Søndergaard, L., Friis-Hansen, L., & Abildstrøm, S. Z. (2011). Kliniske aspekter af Marfans syndrom. Ugeskrift for Laeger, 173(5), 337-42. http://www.ugeskriftet.dk.ep.fjernadgang.kb.dk/portal/page/portal/LAEGERDK/UGESKRIFT_FOR_LAEGER/Artikelvisning?pUrl=/UGESKRIFT_FOR_LAEGER/TIDLIGERE_NUMRE/2011/UFL_2011_5/UFL_2011_173_5_337

Vancouver

Belsing TZ, Lund AM, Søndergaard L, Friis-Hansen L, Abildstrøm SZ. Kliniske aspekter af Marfans syndrom. Ugeskrift for Laeger. 2011;173(5):337-42.

Author

Belsing, Tina Zimmermann ; Lund, Allan Meldgaard ; Søndergaard, Lars ; Friis-Hansen, Lennart ; Abildstrøm, Steen Zabell. / Kliniske aspekter af Marfans syndrom. I: Ugeskrift for Laeger. 2011 ; Bind 173, Nr. 5. s. 337-42.

Bibtex

@article{3c85282ec236477e8c17014cc5d7c9b6,
title = "Kliniske aspekter af Marfans syndrom",
abstract = "Marfan syndrome (MFS) and MFS-related diseases are inherited connective tissue disorders involving several organ systems. The diagnosis of MFS is difficult as the many symptoms overlap with those of other systemic connective tissue diseases. The phenotype is progressive. Effective surgical therapy and standardized follow-up programs have led to an improved lifespan for the affected individuals. Selective angiotensin II, type 1 (AT1) blockers may improve several manifestations of MFS, but the outcome of clinical trials is presently unknown. This review describes the importance of a coordinated strategy for diagnosis, treatment and follow-up.",
author = "Belsing, {Tina Zimmermann} and Lund, {Allan Meldgaard} and Lars S{\o}ndergaard and Lennart Friis-Hansen and Abildstr{\o}m, {Steen Zabell}",
year = "2011",
language = "Dansk",
volume = "173",
pages = "337--42",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "5",

}

RIS

TY - JOUR

T1 - Kliniske aspekter af Marfans syndrom

AU - Belsing, Tina Zimmermann

AU - Lund, Allan Meldgaard

AU - Søndergaard, Lars

AU - Friis-Hansen, Lennart

AU - Abildstrøm, Steen Zabell

PY - 2011

Y1 - 2011

N2 - Marfan syndrome (MFS) and MFS-related diseases are inherited connective tissue disorders involving several organ systems. The diagnosis of MFS is difficult as the many symptoms overlap with those of other systemic connective tissue diseases. The phenotype is progressive. Effective surgical therapy and standardized follow-up programs have led to an improved lifespan for the affected individuals. Selective angiotensin II, type 1 (AT1) blockers may improve several manifestations of MFS, but the outcome of clinical trials is presently unknown. This review describes the importance of a coordinated strategy for diagnosis, treatment and follow-up.

AB - Marfan syndrome (MFS) and MFS-related diseases are inherited connective tissue disorders involving several organ systems. The diagnosis of MFS is difficult as the many symptoms overlap with those of other systemic connective tissue diseases. The phenotype is progressive. Effective surgical therapy and standardized follow-up programs have led to an improved lifespan for the affected individuals. Selective angiotensin II, type 1 (AT1) blockers may improve several manifestations of MFS, but the outcome of clinical trials is presently unknown. This review describes the importance of a coordinated strategy for diagnosis, treatment and follow-up.

M3 - Tidsskriftartikel

VL - 173

SP - 337

EP - 342

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 5

ER -

ID: 40176150